Taro Reschedules Issuance of its Financial Results For the Quarter Ended September 30, 2012 To November 1, 2012 due to Expected Severe Weather Conditions Associated with Hurricane Sandy
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) announced today the postponement of the issuance of its financial results for the quarter ended September 30, 2012, which results were previously announced to be issued on October 30, 2012, due to expected severe weather conditions associated with Hurricane Sandy.
The Company will release the financial results for the quarter ended September 30, 2012 after the market close on Thursday, November 1, 2012. The release will also be available on Taro's website at www.taro.com.
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company's website at www.taro.com.
Taro Pharmaceutical Industries Ltd.
William J. Coote, 914-345-9001